[1] 中华医学会内分泌学分会. 肥胖患者的长期体重管理及药物临床应用指南(2024版). 中华内分泌代谢杂志 2024,40(07):545-564 [2] 张群 等,新医学,2024,55(9):667-684 [3] TREXLER ET, ET. JINT SOC SPORTS NUTR.2014FEB 27;11(1):7 [4] Linong, Ji, et.al Action-China Attitude about obesity among people living with obesity and healthcare professional. Poster-547, 41st ObesityWeek®, October 14-17, 2023, Dallas, TX, USA. [5] Waters H, Graf M. America's Obesity Crisis: The Health and Economic Costs of Excess Weight. Milken Institute; 2018. Accessed February 20, 2024. [6] World Health Organization. World Obesity Day 2022 – Accelerating action to stop obesity. Updated March 4, 2022. Accessed February 20, 2024. https://www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-to-stop-obesity [7] World Obesity Atlas 2023. March 2023. Accessed February 20, 2024. https://s3-eu-west-1.amazonaws.com/wof-files/World_Obesity_Atlas_2023_Report.pdf [8] World Obesity Atlas 2024. March 2023. Accessed March 6, 2024. https://data.worldobesity.org/publications/WOF-Obesity-Atlas-v6.pdf [9] 中华医学会内分泌学分会. 肥胖患者的长期体重管理及药物临床应用指南(2024版)[J]. 中华内分泌代谢杂志,2024,40(7):545-564. DOI:10.3760/cma.j.cn311282-20240412-00149. [10] Nutter S, Eggerichs L A, Nagpal T S, et al. Changing the global obesity narrative to recognize and reduce weight stigma: a position statement from the World Obesity Federation[J]. Obesity Reviews, 2024, 25(1): e13642. [11] Ard_0W2022_Poster_Perceptions of persons with obesity or overweight toward this disease and its treatment. [12] Ferreira-Hermosillo A, de Miguel Ibañez R, Pérez-Dionisio EK, Villalobos-Mata KA. Obesity as a Neuroendocrine Disorder. Arch Med Res. 2023 Dec;54(8):102896. doi: 10.1016/j.arcmed.2023.102896. Epub 2023 Nov 7. PMID: 37945442. [13] 国家卫生健康委员会办公厅《体重管理指导原则(2024年版)》 [14] 中华医学会,等.中华内分泌代谢杂志《肥胖患者的长期体重管理及药物临床应用指南(2024版)》2024,40(07):545-564 [15] 《肥胖诊疗指南》2024版 [16] Rubino F, Puhl R M, Cummings D E, et al. Joint international consensus statement for ending stigma of obesity[J]. Nature medicine, 2020, 26(4): 485-497. |